Acceleron Pharma
XLRN
XLRN was delisted on the 19th of November, 2021.
8 hedge funds and large institutions have $11.7M invested in Acceleron Pharma in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.22M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$2.16M |
| 3 |
WSA
Wall Street Associates
Lajolla,
California
|
+$1.89M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.51M |
| 5 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
+$810K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DCM
1
Driehaus Capital Management
Chicago,
Illinois
| $4.34M | +$4.22M | +195,402 | New |
|
|
2
Invesco
Atlanta,
Georgia
| $2.22M | +$2.16M | +100,000 | New |
|
|
WSA
3
Wall Street Associates
Lajolla,
California
| $1.95M | +$1.89M | +87,500 | New |
|
|
4
Alyeska Investment Group
Chicago,
Illinois
| $1.56M | +$1.51M | +70,000 | New |
|
|
ICAP
5
Independence Capital Asset Partners
Denver,
Colorado
| $835K | +$810K | +37,557 | New |
|
|
MCM
6
Mazama Capital Management
Portland,
Oregon
| $445K | +$431K | +20,000 | New |
|
|
FSA
7
Franklin Street Advisors
Chapel Hill,
North Carolina
| $362K | +$352K | +16,300 | New |
|
|
SSG
8
Summit Securities Group
New York
| $1K | +$712 | +33 | New |
|
XLRN Hedge Fund Activity: Q3 2013 in Review
8 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Acceleron Pharma (XLRN) for Q3 2013, worth a combined $11.7M.
Buyers outnumbered sellers: 8 funds opened new XLRN positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $4.22M.
- 8 institutional investors held Acceleron Pharma (XLRN) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $11.7M of Acceleron Pharma stock for Q3 2013.
- 8 funds opened new Acceleron Pharma positions in Q3 2013 and 0 closed out, a net change of +8 holders.
- The largest Acceleron Pharma buyer in Q3 2013 was Driehaus Capital Management, an estimated $4.22M added.
Based on aggregated 13F filings for Q3 2013.